OWC Pharmaceutical Research Corp (OWCP)

[236T568]

actually, wrong

any R&D expenses that are outsourced or paid with stock, by DEFINITION, would be classified under the R&D category, not the G&A category in the Income Statement

Explanation received from OWCP re: low R&D:

"our R&D is either outsourced to a laboratory so it's booked as G&A or being executed by Dr. Baruch himself and the expense is booked through his equity compensation. The safety study is conducted in a federal hospital (90% of hospitals in Israel are governmental) which is a non-profit organization and as such, when the study will be finished we will just have to cover the direct expenses."